Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant: Clinical Trials Projects

Research Institute of the McGill University Health Centre

$1,777,095.00

Exergaming registry-based trial promoting physical activity in children and adolescents with spinal muscular atrophy

EF 2022-23

Résumé
Spinal muscular atrophy (SMA) is a rare disease that weakens muscles, limits independent physical function, and shortens children's lives. In the last 5 years, new drug therapies have helped children with SMA live longer and get stronger. However, we don't know how best to give these children fun, convenient opportunities to participate in physical activities that help them undertake everyday activities that matter to them. We also need better ways to measure if what we're doing is helping children in a meaningful way. One promising option is using active video exergames, which are computer games designed to make exercise fun, motivating and convenient to undertake at home. In partnership with children with SMA, their therapists, and their doctors, we co-developed an exergame that uses a low-cost sensor to track body movements and measure progress. Seventy-four children with SMA (ages 6-18 years) will participate in either the exergaming treatment for 12 weeks or continue with their usual care where they will continue to benefit from physical activities in their community. All children will wear a small device on their wrist to see how well it measures changes in children's arm movements during their daily activities at home. We will compare children's' and families' perception and satisfaction of their performance in important activities of daily living to evaluate the impact of the exergaming intervention. We will also test children's motor abilities before and after the intervention. Our study results will help us understand whether exergaming is a good way to provide accessible rehabilitation that promotes physical activity and independent participation in activities of daily living for children with SMA. We will also understand how to best measure the impact of our treatments in a meaningful way. Ultimately, we can use this information to make informed care decisions to optimize children's individual outcomes.
Programme
Operating Grant: Clinical Trials Projects
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466339
Name
Oskoui Maryam
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Operating Grant : Clinical Trials Projects
Projecttitle
Exergaming registry-based trial promoting physical activity in children and adolescents with spinal muscular atrophy
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$1,777,095
Cihrequipment2
$0
Programname2
Operating Grant: Clinical Trials Projects
Keyworddelim
Exergaming; Pragmatic Randomized Controlled Trial; Rare Disease; Registry-Based Trial; Rehabilitation; Spinal Muscular Atrophy; Wearable Technology
Abstract
Spinal muscular atrophy (SMA) is a rare disease that weakens muscles, limits independent physical function, and shortens children's lives. In the last 5 years, new drug therapies have helped children with SMA live longer and get stronger. However, we don't know how best to give these children fun, convenient opportunities to participate in physical activities that help them undertake everyday activities that matter to them. We also need better ways to measure if what we're doing is helping children in a meaningful way. One promising option is using active video exergames, which are computer games designed to make exercise fun, motivating and convenient to undertake at home. In partnership with children with SMA, their therapists, and their doctors, we co-developed an exergame that uses a low-cost sensor to track body movements and measure progress. Seventy-four children with SMA (ages 6-18 years) will participate in either the exergaming treatment for 12 weeks or continue with their usual care where they will continue to benefit from physical activities in their community. All children will wear a small device on their wrist to see how well it measures changes in children's arm movements during their daily activities at home. We will compare children's' and families' perception and satisfaction of their performance in important activities of daily living to evaluate the impact of the exergaming intervention. We will also test children's motor abilities before and after the intervention. Our study results will help us understand whether exergaming is a good way to provide accessible rehabilitation that promotes physical activity and independent participation in activities of daily living for children with SMA. We will also understand how to best measure the impact of our treatments in a meaningful way. Ultimately, we can use this information to make informed care decisions to optimize children's individual outcomes.
Competitiondate
202207
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Oskoui, Maryam; Smith, Maureen M; Evans, Alan C; Iturria Medina, Yasser; Levac, Danielle E; Potter, Elizabeth K
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $1,777,095~ $0~